FDA Approves New Diabetes Drug
January 9, 2014 — Yet another new diabetes drug — dapagliflozin, branded as Farxiga — in a class of drugs with helpful effects on weight received final FDA approval on Wednesday. The drug is the product of a joint venture in diabetes by AstraZeneca and Bristol-Meyers Squibb, soon to be wholly owned by AstraZeneca. Dapagliflozin joins canagliflozin (Invokana) in a new […]
